Welcome to the 13th Annual World Clinical Biomarkers & CDx Summit, the highly anticipated gathering that brings together over 600 senior decision makers in the field of biomarkers and companion diagnostics (CDx). This industry-led meeting aims to accelerate the co-development of clinically validated and affordable drug-CDx combinations, overcoming challenges in commercialization, reimbursement, and regulation. With a focus on oncology and other therapeutic areas like NASH and neuroscience, this summit is dedicated to advancing personalized medicine and bringing it to patients faster.
At the summit, you will have the opportunity to connect with directors, heads, and VPs of Clinical Biomarkers, Translational Medicine, Precision Medicine, and Companion Diagnostics. Additionally, drug and diagnostic developers, regulatory experts, payors, and notified bodies will be in attendance. This exclusive event provides a platform for knowledge sharing and networking, enabling you to propel your pipelines and make a significant impact on patient outcomes.
By participating in the 13th Annual World Clinical Biomarkers & CDx Summit, you will gain insights into the latest advancements and breakthroughs in biomarker research, CDx development, and precision medicine. You will have access to expert-led discussions, case studies, and presentations focused on addressing key challenges in the field. The summit will cover topics such as commercialization strategies, reimbursement models, regulatory considerations, and the integration of biomarkers and CDx into clinical trials.
Whether you are involved in oncology, NASH, neuroscience, or other therapeutic areas, this event provides a unique opportunity to collaborate with industry leaders, exchange ideas, and forge partnerships. Together, we can overcome barriers and accelerate the delivery of personalized medicine to patients worldwide.
Join us at the 13th Annual World Clinical Biomarkers & CDx Summit and be a part of the global effort to revolutionize healthcare through the power of biomarkers and companion diagnostics. Together, we can transform patient care and improve outcomes for countless individuals.